{"Sodium-glucose": [0], "cotransporter": [1], "2": [2, 54, 153], "(SGLT2)": [3], "inhibitors": [4, 31], "reduce": [5], "the": [6, 25, 78, 108, 118, 124, 136, 169, 175, 194, 199, 226, 232, 243, 253, 259, 298, 302, 311, 328, 336, 339], "risk": [7], "of": [8, 29, 38, 81, 103, 105, 111, 133, 139, 152, 182, 187, 218, 245, 291, 323, 331, 338, 365], "hospitalization": [9], "for": [10, 61, 91, 130, 375], "heart": [11, 22, 40, 63, 92, 348, 376], "failure": [12, 41, 64, 93, 377], "or": [13, 71, 141, 354], "death": [14, 219, 246], "from": [15, 83, 107, 220, 247, 367], "cardiovascular": [16, 84, 221, 368], "causes": [17, 85, 222, 369], "among": [18], "patients": [19, 51, 113, 292, 332, 342], "with": [20, 52, 274, 277, 293, 313, 343], "stable": [21], "failure.": [23], "However,": [24], "safety": [26], "and": [27, 86, 88, 95, 121, 127, 149, 172, 229, 256, 301, 306, 318, 345, 370, 372, 383], "efficacy": [28], "SGLT2": [30], "when": [32], "initiated": [33, 352], "soon": [34], "after": [35, 155, 356], "an": [36], "episode": [37], "decompensated": [39], "are": [42], "unknown.We": [43], "performed": [44], "a": [45, 131, 150, 360], "multicenter,": [46], "double-blind": [47], "trial": [48, 99], "in": [49, 147, 157, 168, 174, 193, 198, 225, 231, 252, 258, 297, 327, 359], "which": [50], "type": [53], "diabetes": [55, 344], "mellitus": [56], "who": [57], "were": [58, 65, 128, 325], "recently": [59], "hospitalized": [60], "worsening": [62, 347], "randomly": [66], "assigned": [67], "to": [68, 117, 123, 213, 241, 268, 335], "receive": [69], "sotagliflozin": [70, 119, 140, 170, 195, 227, 254, 275, 299, 324, 350], "placebo.": [72, 379], "The": [73, 98, 178, 216, 289, 321], "primary": [74, 163, 188], "end": [75], "point": [76], "was": [77, 143, 191, 223, 250, 271, 283, 295, 310], "total": [79, 110, 363], "number": [80, 181, 364], "deaths": [82, 366], "hospitalizations": [87, 371], "urgent": [89, 373], "visits": [90, 374], "(first": [94], "subsequent": [96], "events).": [97], "ended": [100], "early": [101], "because": [102], "loss": [104], "funding": [106], "sponsor.A": [109], "1222": [112], "underwent": [114], "randomization": [115], "(608": [116], "group": [120, 171, 196, 201, 228, 234, 255, 261, 300, 304], "614": [122], "placebo": [125, 142, 176, 200, 233, 260, 278, 303], "group)": [126], "followed": [129], "median": [132, 151], "9.0": [134], "months;": [135], "first": [137, 340], "dose": [138], "administered": [144], "before": [145, 353], "discharge": [146, 156], "48.8%": [148], "days": [154], "51.2%.": [158], "Among": [159], "these": [160], "patients,": [161], "600": [162], "end-point": [164, 189], "events": [165, 183, 190], "occurred": [166], "(245": [167], "355": [173], "group).": [177], "rate": [179, 217, 244], "(the": [180], "per": [184], "100": [185], "patient-years)": [186], "lower": [192, 362], "than": [197, 276, 378], "(51.0": [202], "vs.": [203, 280, 287], "76.3;": [204], "hazard": [205], "ratio,": [206, 236, 263], "0.67;": [207], "95%": [208, 238, 265], "confidence": [209], "interval": [210], "[CI],": [211], "0.52": [212], "0.85;": [214], "P<0.001).": [215], "10.6": [224], "12.5": [230], "(hazard": [235, 262], "0.84;": [237], "CI,": [239, 266], "0.58": [240], "1.22);": [242], "any": [248], "cause": [249], "13.5": [251], "16.3": [257], "0.82;": [264], "0.59": [267], "1.14).": [269], "Diarrhea": [270], "more": [272], "common": [273], "(6.1%": [279], "3.4%),": [281], "as": [282, 309], "severe": [284], "hypoglycemia": [285], "(1.5%": [286], "0.3%).": [288], "percentage": [290, 312], "hypotension": [294], "similar": [296], "(6.0%": [305], "4.6%,": [307], "respectively),": [308], "acute": [314], "kidney": [315], "injury": [316], "(4.1%": [317], "4.4%,": [319], "respectively).": [320], "benefits": [322], "consistent": [326], "prespecified": [329], "subgroups": [330], "stratified": [333], "according": [334], "timing": [337], "dose.In": [341], "recent": [346], "failure,": [349], "therapy,": [351], "shortly": [355], "discharge,": [357], "resulted": [358], "significantly": [361], "(Funded": [380], "by": [381], "Sanofi": [382], "Lexicon": [384], "Pharmaceuticals;": [385], "SOLOIST-WHF": [386], "ClinicalTrials.gov": [387], "number,": [388], "NCT03521934.).": [389]}